Novo Nordisk has officially launched its groundbreaking weight-loss drug, Wegovy, in China, marking a significant step in addressing obesity in the world’s most populous country. The drug’s approval by Chinese health authorities in June has paved the way for its introduction into the second-largest pharmaceutical market globally. A Solution for 180 Million Obese Individuals in […]